| scholarly article | Q13442814 |
| P819 | ADS bibcode | 2013PLoSO...868742X |
| P356 | DOI | 10.1371/JOURNAL.PONE.0068742 |
| P932 | PMC publication ID | 3714286 |
| P698 | PubMed publication ID | 23874744 |
| P5875 | ResearchGate publication ID | 250926135 |
| P50 | author | Douglas Yee | Q56985470 |
| P2093 | author name string | Robert Kratzke | |
| James R Davie | |||
| Shantanu Banerji | |||
| Fekadu Kassie | |||
| Wayne Xu | |||
| P2860 | cites work | Constructing molecular classifiers for the accurate prognosis of lung adenocarcinoma | Q23916642 |
| Hybrid Models Identified a 12-Gene Signature for Lung Cancer Prognosis and Chemoresponse Prediction | Q23924046 | ||
| A DNA microarray survey of gene expression in normal human tissues | Q24797220 | ||
| Cancer statistics, 2010 | Q27860525 | ||
| A two-gene expression ratio of homeobox 13 and interleukin-17B receptor for prediction of recurrence and survival in women receiving adjuvant tamoxifen | Q28306747 | ||
| A gene expression signature predicts survival of patients with stage I non-small cell lung cancer | Q28764568 | ||
| Gene-expression profiles predict survival of patients with lung adenocarcinoma | Q29614443 | ||
| Oncogenic pathway signatures in human cancers as a guide to targeted therapies | Q29615526 | ||
| Classification of human lung carcinomas by mRNA expression profiling reveals distinct adenocarcinoma subclasses | Q29616071 | ||
| Hepatic stellate cells: protean, multifunctional, and enigmatic cells of the liver | Q29616840 | ||
| Gene expression profiling identifies MMP-12 and ADAMDEC1 as potential pathogenic mediators of pulmonary sarcoidosis | Q30487702 | ||
| Prognostic and predictive gene signature for adjuvant chemotherapy in resected non-small-cell lung cancer | Q30497419 | ||
| Prognostic gene-expression signature of carcinoma-associated fibroblasts in non-small cell lung cancer | Q30499935 | ||
| Translation of microarray data into clinically relevant cancer diagnostic tests using gene expression ratios in lung cancer and mesothelioma | Q30718501 | ||
| Whole-genome gene expression profiling of formalin-fixed, paraffin-embedded tissue samples | Q30974811 | ||
| Gene expression signature of cigarette smoking and its role in lung adenocarcinoma development and survival | Q33320978 | ||
| Gene expression-based prognostic signatures in lung cancer: ready for clinical use? | Q33988433 | ||
| Gene-expression signature predicts postoperative recurrence in stage I non-small cell lung cancer patients | Q34146519 | ||
| Macrophage migration inhibitory factor promotes tumor growth in the context of lung injury and repair | Q34268934 | ||
| Fine-needle aspiration biopsies for gene expression ratio-based diagnostic and prognostic tests in malignant pleural mesothelioma | Q34679620 | ||
| Human RecQL4 helicase plays critical roles in prostate carcinogenesis. | Q34684298 | ||
| Gene expression-based survival prediction in lung adenocarcinoma: a multi-site, blinded validation study | Q34798314 | ||
| Genomics screen in transformed stem cells reveals RNASEH2A, PPAP2C, and ADARB1 as putative anticancer drug targets. | Q34920304 | ||
| Balance of Yin and Yang: ubiquitylation-mediated regulation of p53 and c-Myc | Q35082715 | ||
| Robust gene expression signature from formalin-fixed paraffin-embedded samples predicts prognosis of non-small-cell lung cancer patients | Q35196367 | ||
| survcomp: an R/Bioconductor package for performance assessment and comparison of survival models | Q35526651 | ||
| Development of a serum biomarker panel predicting recurrence in stage I non-small cell lung cancer patients. | Q51323007 | ||
| Three-Gene Prognostic Classifier for Early-Stage Non–Small-Cell Lung Cancer | Q57272624 | ||
| Expression profiling defines a recurrence signature in lung squamous cell carcinoma | Q60185098 | ||
| Gene Expression Signature Predicts Recurrence in Lung Adenocarcinoma | Q60185101 | ||
| Isolation and characterization of vitamin-A-storing lung cells | Q70374042 | ||
| Oncogenic ras induces gastrin gene expression in colon cancer | Q77494235 | ||
| Gene expression signatures for predicting prognosis of squamous cell and adenocarcinomas of the lung | Q80050816 | ||
| Nras and Kras mutation in Japanese lung cancer patients: Genotyping analysis using LightCycler | Q80727167 | ||
| Three-gene expression signature predicts survival in early-stage squamous cell carcinoma of the lung | Q81735736 | ||
| [Increase of BIRC5 gene expression in non-small cell lung cancer and esophageal squamous cell carcinoma does not correlate with expression of genes SMAC/DIABLO and PML encoding its inhibitors] | Q82300273 | ||
| An immune response enriched 72-gene prognostic profile for early-stage non-small-cell lung cancer | Q83133034 | ||
| A practical molecular assay to predict survival in resected non-squamous, non-small-cell lung cancer: development and international validation studies | Q35803022 | ||
| Tumour-derived exosomes and their role in cancer-associated T-cell signalling defects | Q36616153 | ||
| Expression of calcyclin-binding protein/Siah-1 interacting protein in normal and malignant human tissues: an immunohistochemical survey | Q36744057 | ||
| CDC25 phosphatases in cancer cells: key players? Good targets? | Q36849329 | ||
| Cdt1 and Geminin in cancer: markers or triggers of malignant transformation? | Q37175333 | ||
| Genomic prognostic models in early-stage lung cancer | Q37482910 | ||
| The Yin and Yang functions of the Myc oncoprotein in cancer development and as targets for therapy | Q37728617 | ||
| Increased expression of bHLH transcription factor E2A (TCF3) in prostate cancer promotes proliferation and confers resistance to doxorubicin induced apoptosis | Q39352431 | ||
| Silencing of selected glutamate receptor subunits modulates cancer growth. | Q39464328 | ||
| Characterization of a cleavage stimulation factor, 3' pre-RNA, subunit 2, 64 kDa (CSTF2) as a therapeutic target for lung cancer | Q39495682 | ||
| Oncogenic activity of Cdc6 through repression of the INK4/ARF locus | Q40298342 | ||
| EN2 is a candidate oncogene in human breast cancer | Q40399564 | ||
| Gene expression-based, individualized outcome prediction for surgically treated lung cancer patients | Q40519649 | ||
| A two-gene expression ratio predicts clinical outcome in breast cancer patients treated with tamoxifen | Q40546564 | ||
| Non-overlapping and non-cell-type-specific gene expression signatures predict lung cancer survival | Q43747800 | ||
| Deregulation of FCGR2B expression by 1q21 rearrangements in follicular lymphomas | Q43830988 | ||
| A five-gene signature and clinical outcome in non-small-cell lung cancer | Q44736779 | ||
| Metabotropic glutamate receptor subtype-1 is essential for in vivo growth of melanoma | Q46382784 | ||
| p53 and c-myc: how does the cell balance "yin" and "yang"? | Q47605535 | ||
| Genome-wide midrange transcription profiles reveal expression level relationships in human tissue specification | Q48522151 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 7 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | e68742 | |
| P577 | publication date | 2013-07-17 | |
| P1433 | published in | PLOS One | Q564954 |
| P1476 | title | Yin Yang gene expression ratio signature for lung cancer prognosis | |
| P478 | volume | 8 |
| Q39124676 | A 16 Yin Yang gene expression ratio signature for ER+/node- breast cancer |
| Q43985337 | An individualized gene expression signature for prediction of lung adenocarcinoma metastases |
| Q55386590 | Expression of engrailed homeobox 2 regulates the proliferation, migration and invasion of non-small cell lung cancer cells. |
| Q52560707 | Genes and functions from breast cancer signatures. |
| Q38390072 | Prognostic and predictive biomarkers in early stage non-small cell lung cancer: tumor based approaches including gene signatures |
| Q47107372 | The exploration of contrasting pathways in Triple Negative Breast Cancer (TNBC). |
Search more.